Authors:
HOLBROOK KA
KLEIN RS
HARTEL D
ELLIOTT DA
BARSKY TB
ROTHSCHILD LH
LOWY FD
Citation: Ka. Holbrook et al., STAPHYLOCOCCUS-AUREUS NASAL COLONIZATION IN HIV-SEROPOSITIVE AND HIV-SERONEGATIVE DRUG-USERS, Journal of acquired immune deficiency syndromes and human retrovirology, 16(4), 1997, pp. 301-306
Authors:
GOUREVITCH MN
HARTEL D
SCHOENBAUM EE
KLEIN RS
Citation: Mn. Gourevitch et al., LACK OF ASSOCIATION OF INDURATION SIZE WITH HIV-INFECTION AMONG DRUG-USERS REACTING TO TUBERCULIN, American journal of respiratory and critical care medicine, 155(5), 1997, pp. 1817-1817
Authors:
GOUREVITCH MN
HARTEL D
SCHOENBAUM EE
KLEIN RS
Citation: Mn. Gourevitch et al., LACK OF ASSOCIATION OF INDURATION SIZE WITH HIV-INFECTION AMONG DRUG-USERS REACTING TO TUBERCULIN, American journal of respiratory and critical care medicine, 154(4), 1996, pp. 1029-1033
Citation: J. Woiceshyn et D. Hartel, STRATEGIES AND PERFORMANCE OF CANADIAN BIOTECHNOLOGY FIRMS - AN EMPIRICAL-INVESTIGATION, Technovation, 16(5), 1996, pp. 231-243
Authors:
GOUREVITCH MN
HARTEL D
SCHOENBAUM EE
SELWYN PA
DAVENNY K
FRIEDLAND GH
KLEIN RS
Citation: Mn. Gourevitch et al., A PROSPECTIVE-STUDY OF SYPHILIS AND HIV-INFECTION AMONG INJECTION-DRUG USERS RECEIVING METHADONE IN THE BRONX, NY, American journal of public health, 86(8), 1996, pp. 1112-1115
Authors:
ALCABES P
SELWYN PA
DAVENNY K
HARTEL D
BUONO D
SCHOENBAUM EE
KLEIN RS
FRIEDLAND GH
Citation: P. Alcabes et al., LABORATORY MARKERS AND THE RISK OF DEVELOPING HIV-1 DISEASE AMONG INJECTING DRUG-USERS (VOL 8, PG 107, 1994), AIDS, 8(4), 1994, pp. 566-566
Authors:
SILBERSTEIN CH
ODOWD MA
CHARTOCK P
SCHOENBAUM EE
FRIEDLAND G
HARTEL D
MCKEGNEY FP
Citation: Ch. Silberstein et al., A PROSPECTIVE 4-YEAR FOLLOW-UP OF NEUROPSYCHOLOGICAL FUNCTION IN HIV-SEROPOSITIVE AND SERONEGATIVE METHADONE-MAINTAINED PATIENTS, General hospital psychiatry, 15(6), 1993, pp. 351-359